Mawer Investment Management Ltd. Has $123.80 Million Position in Danaher Co. (NYSE:DHR)

Mawer Investment Management Ltd. lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 0.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 445,300 shares of the conglomerate's stock after selling 2,396 shares during the period. Mawer Investment Management Ltd. owned 0.06% of Danaher worth $123,802,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Legal & General Group Plc boosted its stake in Danaher by 2.4% during the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock valued at $1,490,112,000 after buying an additional 139,989 shares in the last quarter. Capital Research Global Investors grew its stake in shares of Danaher by 1.0% in the 1st quarter. Capital Research Global Investors now owns 5,125,470 shares of the conglomerate's stock worth $1,279,932,000 after purchasing an additional 52,679 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Danaher by 2.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate's stock worth $849,195,000 after purchasing an additional 85,081 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Danaher by 22.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock valued at $761,475,000 after purchasing an additional 563,546 shares during the last quarter. Finally, Swedbank AB bought a new stake in Danaher during the first quarter worth approximately $676,545,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 0.2 %

NYSE:DHR traded down $0.44 during mid-day trading on Monday, reaching $230.06. The stock had a trading volume of 3,770,935 shares, compared to its average volume of 2,764,637. The stock has a market cap of $166.17 billion, a P/E ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85. The business's 50 day moving average is $262.20 and its 200 day moving average is $260.57. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a fifty-two week low of $207.63 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.02 EPS. As a group, sell-side analysts predict that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.47%. Danaher's dividend payout ratio (DPR) is presently 20.61%.

Analysts Set New Price Targets

A number of brokerages have recently commented on DHR. Robert W. Baird cut their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. StockNews.com raised Danaher from a "hold" rating to a "buy" rating in a report on Wednesday, November 6th. Barclays dropped their price target on Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 23rd. Wells Fargo & Company started coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price objective for the company. Finally, Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $287.16.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company's stock, valued at $1,130,374.44. This represents a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.